The FY2025 (Sep) proxy of Embecta names 17 peer companies for pay. Among Embecta and these peers, CEO pay was 4th highest of 8 and total shareholder return was 5th highest of 8.
4th highest of 8in Embecta and its pay peers, FY2025 (Sep) by CEO pay:
$6.7M$18.9M
5th highest of 8in Embecta and its pay peers, FY2025 (Sep) by total shareholder return:
$19$134
Pay peer group, FY2025 (Sep) proxy
| Insulet | ||
| Cooper Companies | ||
| Resmed | ||
| Integra Lifesciences Holdings | ||
| CONMED | ||
| West Pharmaceutical Services | ||
| Teleflex | ||
| Avanos Medical, Inc | Not disclosed | Not disclosed |
| Bio-Rad Laboratories, Inc. | Not disclosed | Not disclosed |
| Dexcom | Not disclosed | Not disclosed |
| Haemonetics | Not disclosed | Not disclosed |
| ICU Medical, Inc. | Not disclosed | Not disclosed |
| Integer Holdings | Not disclosed | Not disclosed |
| Nevro Corp. | Not disclosed | Not disclosed |
| Orthofix Medical | Not disclosed | Not disclosed |
| Tandem Diabetes Care | Not disclosed | Not disclosed |
| Waters Corporation | Not disclosed | Not disclosed |
17 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.